These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 35394803)

  • 41. Internally Versus Externally Cued Speech in Parkinson's Disease and Cerebellar Disease.
    Weir-Mayta P; Spencer KA; Eadie TL; Yorkston K; Savaglio S; Woollcott C
    Am J Speech Lang Pathol; 2017 Jun; 26(2S):583-595. PubMed ID: 28654941
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intensive treatment of dysarthria secondary to stroke.
    Mahler LA; Ramig LO
    Clin Linguist Phon; 2012 Aug; 26(8):681-94. PubMed ID: 22774928
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Acoustic changes in the speech of children with cerebral palsy following an intensive program of dysarthria therapy.
    Pennington L; Lombardo E; Steen N; Miller N
    Int J Lang Commun Disord; 2018 Jan; 53(1):182-195. PubMed ID: 28714530
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dysprosody and stimulus effects in Cantonese speakers with Parkinson's disease.
    Ma JK; Whitehill T; Cheung KS
    Int J Lang Commun Disord; 2010; 45(6):645-55. PubMed ID: 19995207
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hybridizing conversational and clear speech to investigate the source of increased intelligibility in speakers with Parkinson's disease.
    Tjaden K; Kain A; Lam J
    J Speech Lang Hear Res; 2014 Aug; 57(4):1191-205. PubMed ID: 24686409
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Investigating Acoustic Correlates of Intelligibility Gains and Losses During Slowed Speech: A Hybridization Approach.
    van Brenk F; Kain A; Tjaden K
    Am J Speech Lang Pathol; 2021 Jun; 30(3S):1343-1360. PubMed ID: 34048663
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of an intensive voice treatment on articulatory function and speech intelligibility in children with motor speech disorders: A phase one study.
    Langlois C; Tucker BV; Sawatzky AN; Reed A; Boliek CA
    J Commun Disord; 2020; 86():106003. PubMed ID: 32505858
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relationship between acoustic measures and judgments of intelligibility in Parkinson's disease: a within-speaker approach.
    Feenaughty L; Tjaden K; Sussman J
    Clin Linguist Phon; 2014 Nov; 28(11):857-78. PubMed ID: 24874184
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Cross-Language Study of Acoustic Predictors of Speech Intelligibility in Individuals With Parkinson's Disease.
    Kim Y; Choi Y
    J Speech Lang Hear Res; 2017 Sep; 60(9):2506-2518. PubMed ID: 28821018
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of intensive voice treatment (the Lee Silverman Voice Treatment [LSVT]) on vowel articulation in dysarthric individuals with idiopathic Parkinson disease: acoustic and perceptual findings.
    Sapir S; Spielman JL; Ramig LO; Story BH; Fox C
    J Speech Lang Hear Res; 2007 Aug; 50(4):899-912. PubMed ID: 17675595
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Speech treatment for Hebrew-speaking adolescents and young adults with developmental dysarthria: A comparison of mSIT and Beatalk.
    Carl M; Levy ES; Icht M
    Int J Lang Commun Disord; 2022 May; 57(3):660-679. PubMed ID: 35363414
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treating disordered speech and voice in Parkinson's disease online: a randomized controlled non-inferiority trial.
    Constantinescu G; Theodoros D; Russell T; Ward E; Wilson S; Wootton R
    Int J Lang Commun Disord; 2011; 46(1):1-16. PubMed ID: 21281410
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acoustic-phonetic contrasts and intelligibility in the dysarthria associated with mixed cerebral palsy.
    Ansel BM; Kent RD
    J Speech Hear Res; 1992 Apr; 35(2):296-308. PubMed ID: 1573870
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of the LSVT on vowel articulation and coarticulation in Parkinson's disease.
    Sauvageau VM; Roy JP; Langlois M; Macoir J
    Clin Linguist Phon; 2015 Jun; 29(6):424-40. PubMed ID: 25688915
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cepstral analysis of hypokinetic and ataxic voices: correlations with perceptual and other acoustic measures.
    Jannetts S; Lowit A
    J Voice; 2014 Nov; 28(6):673-80. PubMed ID: 24836365
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acoustic properties of vowel production in Mandarin-speaking patients with post-stroke dysarthria.
    Mou Z; Chen Z; Yang J; Xu L
    Sci Rep; 2018 Sep; 8(1):14188. PubMed ID: 30242251
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of Deep-Brain Stimulation on Speech: Perceptual and Acoustic Data.
    Kim Y; Thompson A; Nip ISB
    J Speech Lang Hear Res; 2024 Apr; 67(4):1090-1106. PubMed ID: 38498664
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A serious game for speech training in dysarthric speakers with Parkinson's disease: Exploring therapeutic efficacy and patient satisfaction.
    Ganzeboom M; Bakker M; Beijer L; Strik H; Rietveld T
    Int J Lang Commun Disord; 2022 Jul; 57(4):808-821. PubMed ID: 35338751
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Guidelines for Speech Recording and Acoustic Analyses in Dysarthrias of Movement Disorders.
    Rusz J; Tykalova T; Ramig LO; Tripoliti E
    Mov Disord; 2021 Apr; 36(4):803-814. PubMed ID: 33373483
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Singing and Speaking Ability in Parkinson's Disease and Spinocerebellar Ataxia.
    Kim Y; Sidtis D; Sidtis JJ
    J Speech Lang Hear Res; 2023 Jan; 66(1):126-153. PubMed ID: 36608288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.